ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today that Dr. Howard McLeod, Pharm.D., FASCO, FCCP, has ...
SAN DIEGO--(BUSINESS WIRE)--ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing RNA-targeting therapeutics, today announced the expansion of their leadership team through ...
Paul Capital Partners today announced that Ken Macleod, Ph.D., has been promoted to Partner. Based in Paul Capital's London office, Dr. Macleod is responsible for sourcing, evaluating and negotiating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results